559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)

L Paz-Ares, O Juan-Vidal + Show 17 more

Open Access

https://doi.org/10.1016/j.annonc.2020.08.673

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Sep 1, 2020
Citations: 2	License type: publisher-specific-oa

Affiliation: Hospital Universitario 12 De Octubre, Hospital Universitari i Politècnic La Fe, Institut Català d'Oncologia, Aix-Marseille University, Vall d'Hebron Hospital Universitari, Hôpital Laennec, Hôpital Nord, Centre Hospitalier Universitaire de Nantes, Marche Polytechnic University, Institut Gustave Roussy, Policlinico S.Orsola-Malpighi, Bristol-Myers Squibb (United States)

#Etoposide And Cisplatin #Small Cell Lung Cancer + Show 6 more

Abstract
Full-Text PDF
Similar Papers

Abstract

559P Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)

Full Text

Published version (

Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title

Journal

Date

Author

View more papers

Translate this paper in your preferred language
Listen to the abstract of this paper

Save
Share
Export